As the need for organ transplantation increases and the waiting list continues to grow, successful utilization and transplantation of as many available donor organs as possible has become paramount. While short-term outcomes have continued to improve and the incidence of acute rejection episodes has decreased, there has been only modest improvement in longer term outcomes, due to a variety of factors. Clearly, the greater use of extended criteria donors (ECD) and donation after cardiac death...
Read More
The recognition of risk factors is essential for ensuring optimal outcomes after kidney transplantation. The dynamically changing characteristics of recipients and donors are transforming allocation policy, patient care, and outcomes. The development of a new and improved process for identifying and assessing risk is urgently needed. The American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST) 2008 Winter Symposia focused on emerging issues in high...
Read More
Post-transplant lymphoproliferative disorders (PTLD) encompass a wide spectrum of mainly B-cell lymphoproliferative disorders with severity ranging from benign polyclonal syndromes to malignant monoclonal lymphoproliferative malignant diseases. At clinical presentation, PTLD may be localized or widely disseminated, and may commonly involve the transplanted allograft.
Epstein-Barr virus (EBV) is the causative agent of the vast majority of PTLD. Patients who are EBV...
Read More
This activity presented by...
Raymund R. Razonable, MD
Consultant, Division of Infectious Diseases
Section of Transplant Infectious Diseases
Mayo...
